The Future of Access, a Live Podcast Recording from the ACCESS US 2025 Conference
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
The Future of Access, a Live Podcast Recording from the ACCESS US 2025 Conference
-
Narrado por:
-
De:
At ACCESS US 2025, our live podcast The Future of Access features four experts exploring how to improve drug affordability and access while maintaining innovation. With rising drug costs, we ask: What bold models are emerging? We cover benefit design, PBMs, AI, evolving pharmacy models, and whether markets can act before regulation.
- Conference Overview
- Sarah Emond – ICER
- John O’Brien – National Pharmaceutical Council
- Annette Powers – Bristol Myers Squibb
- Ray Pressburger – Accenture
- Stuart Altman – Power, Politics and Universal Health Care
- PBMs
- 340B Program
- Copay Maximizers
- Net Price
- Lilly Direct
- Indolent Disease, PFS
- Concomitant Drug
- HIV & AZT
- Orphan Drugs
- Calquence vs Imbruvica
- Value-Based Contracts
- Outcome-Based Contracts
- Disruptive PBMs
- CostPlus Drugs
- Fair Access 2024
- Drug Rebates
- Drug Carve-Outs
- Dynamic Pricing
- Accelerated Approvals
- ICER Assessment
Questions? Email comments@prescriptionforbetteraccess.com.
Follow us on X, LinkedIn, YouTube, and Threads.
Todavía no hay opiniones